Cell Cycle and Senescence Cooperativity of E-cadherin and Smad 4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis
暂无分享,去创建一个
Jeffrey E. Green | C. Deng | H. Kim | D. Park | Jun Won Park | D. Kim | S. H. Jang | N. Lim | S. Jang
[1] B. Nordlinger,et al. Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor , 2012, Diagnostic Pathology.
[2] Joseph T. Roland,et al. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. , 2012, Gastroenterology.
[3] K. Miyazono,et al. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. , 2011, The American journal of pathology.
[4] Y. Eishi,et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer , 2011, Gut.
[5] Gerald C. Chu,et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression , 2011, Nature.
[6] Yong-jig Cho,et al. Antimetastatic role of Smad4 signaling in colorectal cancer. , 2010, Gastroenterology.
[7] P. Guilford,et al. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. , 2009, Cancer research.
[8] J. Merchant,et al. Prospective identification of a multilineage progenitor in murine stomach epithelium. , 2007, Gastroenterology.
[9] Bernhard Schmierer,et al. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.
[10] Li-hui Wang,et al. Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression , 2007, Clinical Cancer Research.
[11] T. Joh,et al. Bone morphogenetic protein 2 induced differentiation toward superficial epithelial cells in the gastric mucosa , 2006, Journal of Gastroenterology.
[12] Jos Jonkers,et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. , 2006, Cancer cell.
[13] T. Tsukamoto,et al. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. , 2006, Gastroenterology.
[14] N. Toribara,et al. The Adherent Gastric Mucous Layer Is Composed of Alternating Layers of MUC5AC and MUC6 Mucin Proteins , 2004, Digestive Diseases and Sciences.
[15] Daniel Metzger,et al. Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.
[16] Y. Yuasa,et al. BMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cells. , 2004, Biochemical and biophysical research communications.
[17] B. Jenkins,et al. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. , 2004, Gastroenterology.
[18] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[19] C. V. D. van de Velde,et al. Gastric cancer: epidemiology, pathology and treatment. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] J. Foidart,et al. TRANSACTIVATION OF VIMENTIN BY BETA-CATENIN IN HUMAN BREAST CANCER CELLS , 2003, International Journal of Gynecologic Cancer.
[21] Birgit Luber,et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. , 2002, The American journal of pathology.
[22] R. Kemler,et al. E-cadherin is a survival factor for the lactating mouse mammary gland , 2002, Mechanisms of Development.
[23] L. Aaltonen,et al. Screening E‐cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred , 2002, Human mutation.
[24] C. Deng,et al. Generation of Smad4/Dpc4 conditional knockout mice , 2002, Genesis.
[25] C Caldas,et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. , 2001, Gastroenterology.
[26] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[27] R. Knuechel,et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] C. Caldas,et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma , 2001, Oncogene.
[29] Lin Chen,et al. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice , 2000, Oncogene.
[30] T. Wang,et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. , 2000, Gastroenterology.
[31] M. Rudnicki,et al. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[32] Doris Wedlich,et al. The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression , 1999, Molecular and Cellular Biology.
[33] W F Bodmer,et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Brabletz,et al. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. , 1999, The American journal of pathology.
[35] Hiroyuki Miyoshi,et al. Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes , 1998, Cell.
[36] J. Rossant,et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. , 1998, Genes & development.
[37] K M Leung,et al. Censoring issues in survival analysis. , 1997, Annual review of public health.
[38] O. Madsen,et al. Pancreatic-duodenal homeobox 1 -role in gastric endocrine patterning , 1996, Mechanisms of Development.
[39] P. Chambon,et al. Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.
[40] H. Yokozaki,et al. LETTER TO THE EDITOR. THE SEQUENTIAL ACCUMULATION OF GENETIC ALTERATIONS CHARACTERISTIC OF THE COLORECTAL ADENOMA‐CARCINOMA SEQUENCE DOES NOT OCCUR BETWEEN GASTRIC ADENOMA AND ADENOCARCINOMA , 1996, The Journal of pathology.
[41] H. Höfler,et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. , 1994, Cancer research.